对肝细胞癌免疫治疗的综合性审查:目前的状况和未来的前景
Swetha Pulakuntla1, Gouthami Kuruvalli1, Mrinalini Mohan2
1Department of Biochemistry, REVA University, Yelahanka, IndiaBangalore.
International reviews of immunology
|January 14, 2026
概括
肝细胞癌 (HCC) 免疫疗法显示出希望,但免疫逃避等挑战仍然存在. 未来的战略重点是精准医学和组合疗法,以改善肝癌的治疗反应.
科学领域:
- 肝病学和免疫学 肝病学和免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 目前对晚期HCC的治疗方法的疗效有限.
- 免疫疗法提供了一种针对肝癌细胞的新方法.
研究的目的:
- 提供针对HCC的免疫治疗策略的最新审查.
- 为了突出免疫检查点抑制剂 (ICI) 和新抗原疫苗等关键模式.
- 讨论预测生物标志物,如瘤突变负担 (TMB).
主要方法:
- 对HCC免疫疗法的当前文献的综述.
- 对针对PD-1/PD-L1和CTLA-4的免疫检查点抑制剂的分析.
- 探索新的免疫标和组合策略.
主要成果:
- 免疫疗法,特别是ICI,在HCC治疗中显示出具有变革潜力.
- 像TMB这样的预测性生物标志物对于治疗反应至关重要.
- 挑战包括免疫逃避,抵抗和免疫抑制瘤微环境.
结论:
- 优化HCC免疫疗法需要解决抵抗机制和瘤微环境.
- 整合基因组洞察力和人工智能驱动的生物标志物发现至关重要.
- 以分子分析为指导的精密免疫疗法有望改善患者分层和疗效.
更多相关视频
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
1.7K
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.9K
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Vaccines
952
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
952
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
